Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Though it has been available in the U.S. for a fraction of time compared to the well-established laser vision correction procedures PRK and LASIK, SMILE has quickly become the dominant procedure in the practices of many refractive surgeons.
Clara Chan, MD, Cornea editor, shared an experience that emphasizes the value patient history can have on a diagnosis, in this case recurrent subconjunctival hemorrhages from conjunctivochalasis, which is the focus of an article in the section, as well as other issue highlights.
While in recent months mask use has been relaxed somewhat as health guidelines are updated to reflect increased vaccination status and declining case numbers, there are situations where mask wear continues. These have been credited with playing a role in saving lives, but they have been associated with some unintended ocular consequences as well.
Underdiagnosed, often neglected, and much more common than clinicians realize is how some physicians describe conjunctivochalasis. This article is a deep dive into the condition, its diagnosis, and management options.
Numerous studies have looked at different approaches to using bevacizumab and other anti-VEGF agents for anterior segment surgery. Several experts discussed their use and study of bevacizumab, particularly relating to corneal neovascularization and in corneal transplants.
Keratoprosthesis is an active area of research and development with recent innovations and updates to some devices in the keratoprosthesis field as a whole.
Ophthalmology will see its first major live meeting since the pandemic started with the 2021 ASCRS Annual Meeting. “Just as the live meeting will be reflective of our interesting times, this issue of EyeWorld is a product of our unique year, covering many topics that will help the modern ophthalmologist and glaucoma specialist succeed,” said Nathan Radcliffe, MD, Glaucoma editor.
Glaucoma should not necessarily be an immediate contraindication to premium cataract surgery technologies, such as toric and presbyopia-correcting IOLs and FLACS. Reay Brown, MD, Paul Harasymowycz, MD, and Joey Hsia, MD, said there are situations where these IOL technologies are suited for glaucoma patients, but the decision to offer them is not as straightforward.
Some MIGS options are approved only in conjunction with cataract surgery, while others are not limited in this way. Three ophthalmologists EyeWorld spoke with think there is a value in uncoupling some MIGS procedures from cataract surgery, yet two of the three do not perform off-label standalone MIGS.
Infection is a risk for any ocular surgery, but there are a few reasons why there isn’t a lot of discussion about infection when it comes to glaucoma procedures. MIGS, which have become increasingly common, have a lower infection risk profile compared to incisional glaucoma surgery.